nodes	percent_of_prediction	percent_of_DWPC	metapath
Ramelteon—Parkinson's disease—Rivastigmine—Alzheimer's disease	0.361	0.5	CpDpCtD
Ramelteon—Parkinson's disease—Memantine—Alzheimer's disease	0.361	0.5	CpDpCtD
Ramelteon—CYP2C19—Memantine—Alzheimer's disease	0.0719	0.383	CbGbCtD
Ramelteon—CYP3A4—Rivastigmine—Alzheimer's disease	0.0502	0.267	CbGbCtD
Ramelteon—CYP3A4—Donepezil—Alzheimer's disease	0.0401	0.213	CbGbCtD
Ramelteon—CYP3A4—Galantamine—Alzheimer's disease	0.0258	0.137	CbGbCtD
Ramelteon—MTNR1A—forebrain—Alzheimer's disease	0.0025	0.284	CbGeAlD
Ramelteon—MTNR1A—telencephalon—Alzheimer's disease	0.0023	0.261	CbGeAlD
Ramelteon—Thinking abnormal—Memantine—Alzheimer's disease	0.00157	0.0439	CcSEcCtD
Ramelteon—MTNR1A—nervous system—Alzheimer's disease	0.00136	0.154	CbGeAlD
Ramelteon—MTNR1A—central nervous system—Alzheimer's disease	0.00131	0.148	CbGeAlD
Ramelteon—Mental disability—Memantine—Alzheimer's disease	0.00125	0.0349	CcSEcCtD
Ramelteon—Mental disability—Rivastigmine—Alzheimer's disease	0.00122	0.0341	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Galantamine—Alzheimer's disease	0.00119	0.0333	CcSEcCtD
Ramelteon—Depression—Galantamine—Alzheimer's disease	0.00114	0.0318	CcSEcCtD
Ramelteon—MTNR1A—brain—Alzheimer's disease	0.00104	0.118	CbGeAlD
Ramelteon—Influenza—Donepezil—Alzheimer's disease	0.000994	0.0278	CcSEcCtD
Ramelteon—Influenza—Memantine—Alzheimer's disease	0.000903	0.0252	CcSEcCtD
Ramelteon—Depression—Donepezil—Alzheimer's disease	0.000884	0.0247	CcSEcCtD
Ramelteon—Dysgeusia—Galantamine—Alzheimer's disease	0.000875	0.0244	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Memantine—Alzheimer's disease	0.000839	0.0234	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Rivastigmine—Alzheimer's disease	0.000821	0.0229	CcSEcCtD
Ramelteon—Depression—Memantine—Alzheimer's disease	0.000803	0.0224	CcSEcCtD
Ramelteon—Depression—Rivastigmine—Alzheimer's disease	0.000785	0.0219	CcSEcCtD
Ramelteon—Arthralgia—Galantamine—Alzheimer's disease	0.000761	0.0212	CcSEcCtD
Ramelteon—Myalgia—Galantamine—Alzheimer's disease	0.000761	0.0212	CcSEcCtD
Ramelteon—Dysgeusia—Donepezil—Alzheimer's disease	0.000678	0.0189	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000665	0.0186	CcSEcCtD
Ramelteon—Insomnia—Galantamine—Alzheimer's disease	0.00066	0.0184	CcSEcCtD
Ramelteon—Somnolence—Galantamine—Alzheimer's disease	0.000649	0.0181	CcSEcCtD
Ramelteon—Fatigue—Galantamine—Alzheimer's disease	0.000629	0.0176	CcSEcCtD
Ramelteon—Dysgeusia—Memantine—Alzheimer's disease	0.000616	0.0172	CcSEcCtD
Ramelteon—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000603	0.0168	CcSEcCtD
Ramelteon—Arthralgia—Donepezil—Alzheimer's disease	0.00059	0.0165	CcSEcCtD
Ramelteon—Myalgia—Donepezil—Alzheimer's disease	0.00059	0.0165	CcSEcCtD
Ramelteon—Arthralgia—Memantine—Alzheimer's disease	0.000535	0.0149	CcSEcCtD
Ramelteon—Myalgia—Memantine—Alzheimer's disease	0.000535	0.0149	CcSEcCtD
Ramelteon—Arthralgia—Rivastigmine—Alzheimer's disease	0.000524	0.0146	CcSEcCtD
Ramelteon—Myalgia—Rivastigmine—Alzheimer's disease	0.000524	0.0146	CcSEcCtD
Ramelteon—Asthenia—Galantamine—Alzheimer's disease	0.000523	0.0146	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000515	0.0144	CcSEcCtD
Ramelteon—Insomnia—Donepezil—Alzheimer's disease	0.000511	0.0143	CcSEcCtD
Ramelteon—Somnolence—Donepezil—Alzheimer's disease	0.000503	0.014	CcSEcCtD
Ramelteon—Diarrhoea—Galantamine—Alzheimer's disease	0.000499	0.0139	CcSEcCtD
Ramelteon—Fatigue—Donepezil—Alzheimer's disease	0.000487	0.0136	CcSEcCtD
Ramelteon—Dizziness—Galantamine—Alzheimer's disease	0.000482	0.0135	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000468	0.0131	CcSEcCtD
Ramelteon—Insomnia—Memantine—Alzheimer's disease	0.000464	0.013	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000458	0.0128	CcSEcCtD
Ramelteon—Headache—Galantamine—Alzheimer's disease	0.000457	0.0128	CcSEcCtD
Ramelteon—Somnolence—Memantine—Alzheimer's disease	0.000456	0.0127	CcSEcCtD
Ramelteon—Insomnia—Rivastigmine—Alzheimer's disease	0.000454	0.0127	CcSEcCtD
Ramelteon—Somnolence—Rivastigmine—Alzheimer's disease	0.000446	0.0125	CcSEcCtD
Ramelteon—Fatigue—Memantine—Alzheimer's disease	0.000443	0.0124	CcSEcCtD
Ramelteon—Nausea—Galantamine—Alzheimer's disease	0.000433	0.0121	CcSEcCtD
Ramelteon—Fatigue—Rivastigmine—Alzheimer's disease	0.000433	0.0121	CcSEcCtD
Ramelteon—Asthenia—Donepezil—Alzheimer's disease	0.000406	0.0113	CcSEcCtD
Ramelteon—Diarrhoea—Donepezil—Alzheimer's disease	0.000387	0.0108	CcSEcCtD
Ramelteon—Dizziness—Donepezil—Alzheimer's disease	0.000374	0.0104	CcSEcCtD
Ramelteon—Asthenia—Memantine—Alzheimer's disease	0.000368	0.0103	CcSEcCtD
Ramelteon—Asthenia—Rivastigmine—Alzheimer's disease	0.00036	0.0101	CcSEcCtD
Ramelteon—Headache—Donepezil—Alzheimer's disease	0.000354	0.00989	CcSEcCtD
Ramelteon—Diarrhoea—Memantine—Alzheimer's disease	0.000351	0.00981	CcSEcCtD
Ramelteon—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000344	0.00959	CcSEcCtD
Ramelteon—Dizziness—Memantine—Alzheimer's disease	0.000339	0.00948	CcSEcCtD
Ramelteon—Nausea—Donepezil—Alzheimer's disease	0.000336	0.00938	CcSEcCtD
Ramelteon—Dizziness—Rivastigmine—Alzheimer's disease	0.000332	0.00927	CcSEcCtD
Ramelteon—Headache—Memantine—Alzheimer's disease	0.000322	0.00898	CcSEcCtD
Ramelteon—Headache—Rivastigmine—Alzheimer's disease	0.000315	0.00878	CcSEcCtD
Ramelteon—Nausea—Memantine—Alzheimer's disease	0.000305	0.00851	CcSEcCtD
Ramelteon—Nausea—Rivastigmine—Alzheimer's disease	0.000298	0.00833	CcSEcCtD
Ramelteon—CYP3A4—nervous system—Alzheimer's disease	0.000154	0.0175	CbGeAlD
Ramelteon—CYP3A4—central nervous system—Alzheimer's disease	0.000149	0.0169	CbGeAlD
Ramelteon—MTNR1B—Signaling Pathways—CRH—Alzheimer's disease	5.18e-05	0.00114	CbGpPWpGaD
Ramelteon—CYP2C19—Arachidonic acid metabolism—PTGS2—Alzheimer's disease	5.16e-05	0.00113	CbGpPWpGaD
Ramelteon—CYP1A2—Biological oxidations—MAOB—Alzheimer's disease	5.15e-05	0.00113	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—CCR5—Alzheimer's disease	5.11e-05	0.00112	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—CCR5—Alzheimer's disease	5.11e-05	0.00112	CbGpPWpGaD
Ramelteon—CYP2C19—Biological oxidations—PTGS1—Alzheimer's disease	5.01e-05	0.0011	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—HTR2A—Alzheimer's disease	5e-05	0.0011	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—HTR2A—Alzheimer's disease	5e-05	0.0011	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—DHCR24—Alzheimer's disease	4.97e-05	0.00109	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—NPS—Alzheimer's disease	4.91e-05	0.00108	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—NPS—Alzheimer's disease	4.91e-05	0.00108	CbGpPWpGaD
Ramelteon—CYP2C19—Biological oxidations—CYP2D6—Alzheimer's disease	4.91e-05	0.00108	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—PPP3CA—Alzheimer's disease	4.89e-05	0.00107	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—PPP3CA—Alzheimer's disease	4.89e-05	0.00107	CbGpPWpGaD
Ramelteon—CYP2C19—Metapathway biotransformation—CYP2D6—Alzheimer's disease	4.85e-05	0.00106	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—F2—Alzheimer's disease	4.83e-05	0.00106	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—F2—Alzheimer's disease	4.83e-05	0.00106	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—PTK2B—Alzheimer's disease	4.82e-05	0.00106	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—PTK2B—Alzheimer's disease	4.82e-05	0.00106	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—SST—Alzheimer's disease	4.69e-05	0.00103	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—NTRK2—Alzheimer's disease	4.69e-05	0.00103	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—GAB2—Alzheimer's disease	4.69e-05	0.00103	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—SST—Alzheimer's disease	4.69e-05	0.00103	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—NTRK2—Alzheimer's disease	4.69e-05	0.00103	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—GAB2—Alzheimer's disease	4.69e-05	0.00103	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—CALM1—Alzheimer's disease	4.67e-05	0.00102	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—CALM1—Alzheimer's disease	4.67e-05	0.00102	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—GSK3A—Alzheimer's disease	4.65e-05	0.00102	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—GSK3A—Alzheimer's disease	4.65e-05	0.00102	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	4.61e-05	0.00101	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—APP—Alzheimer's disease	4.57e-05	0.001	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—APP—Alzheimer's disease	4.57e-05	0.001	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—F2—Alzheimer's disease	4.39e-05	0.000961	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—F2—Alzheimer's disease	4.39e-05	0.000961	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—PLCB1—Alzheimer's disease	4.31e-05	0.000944	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—PLCB1—Alzheimer's disease	4.31e-05	0.000944	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—Alzheimer's disease	4.3e-05	0.000941	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	4.25e-05	0.000932	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—NGFR—Alzheimer's disease	4.02e-05	0.000881	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—NGFR—Alzheimer's disease	4.02e-05	0.000881	CbGpPWpGaD
Ramelteon—CYP1A2—Arachidonic acid metabolism—PTGS2—Alzheimer's disease	4.02e-05	0.000881	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Alzheimer's disease	4e-05	0.000876	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—CREB1—Alzheimer's disease	4e-05	0.000876	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—CREB1—Alzheimer's disease	4e-05	0.000876	CbGpPWpGaD
Ramelteon—CYP3A4—Biological oxidations—MAOB—Alzheimer's disease	3.97e-05	0.000871	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—ADAM10—Alzheimer's disease	3.93e-05	0.000861	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—ADAM10—Alzheimer's disease	3.93e-05	0.000861	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—CCL2—Alzheimer's disease	3.91e-05	0.000857	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—CCL2—Alzheimer's disease	3.91e-05	0.000857	CbGpPWpGaD
Ramelteon—CYP1A2—Biological oxidations—PTGS1—Alzheimer's disease	3.9e-05	0.000855	CbGpPWpGaD
Ramelteon—CYP1A2—Biological oxidations—CYP2D6—Alzheimer's disease	3.83e-05	0.000839	CbGpPWpGaD
Ramelteon—CYP1A2—Metapathway biotransformation—CYP2D6—Alzheimer's disease	3.78e-05	0.000827	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—S100B—Alzheimer's disease	3.71e-05	0.000814	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—S100B—Alzheimer's disease	3.71e-05	0.000814	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	3.59e-05	0.000787	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—IGF2—Alzheimer's disease	3.54e-05	0.000775	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—IGF2—Alzheimer's disease	3.54e-05	0.000775	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—IGF1R—Alzheimer's disease	3.42e-05	0.000749	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—IGF1R—Alzheimer's disease	3.42e-05	0.000749	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—Alzheimer's disease	3.38e-05	0.000741	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	3.31e-05	0.000726	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—LPL—Alzheimer's disease	3.28e-05	0.000718	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—LPL—Alzheimer's disease	3.28e-05	0.000718	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—MEF2C—Alzheimer's disease	3.25e-05	0.000712	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—MEF2C—Alzheimer's disease	3.25e-05	0.000712	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—PRKCG—Alzheimer's disease	3.19e-05	0.000698	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—PRKCG—Alzheimer's disease	3.19e-05	0.000698	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—Alzheimer's disease	3.11e-05	0.000681	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—NGF—Alzheimer's disease	3.11e-05	0.00068	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—NGF—Alzheimer's disease	3.11e-05	0.00068	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CCR5—Alzheimer's disease	3.02e-05	0.000662	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CCR5—Alzheimer's disease	3.02e-05	0.000662	CbGpPWpGaD
Ramelteon—CYP3A4—Biological oxidations—PTGS1—Alzheimer's disease	3.01e-05	0.00066	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—HTR2A—Alzheimer's disease	2.96e-05	0.000648	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—HTR2A—Alzheimer's disease	2.96e-05	0.000648	CbGpPWpGaD
Ramelteon—CYP3A4—Biological oxidations—CYP2D6—Alzheimer's disease	2.95e-05	0.000647	CbGpPWpGaD
Ramelteon—CYP3A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	2.91e-05	0.000638	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Alzheimer's disease	2.9e-05	0.000635	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Alzheimer's disease	2.9e-05	0.000635	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—DHCR24—Alzheimer's disease	2.84e-05	0.000622	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CALM1—Alzheimer's disease	2.76e-05	0.000604	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CALM1—Alzheimer's disease	2.76e-05	0.000604	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—APOE—Alzheimer's disease	2.75e-05	0.000602	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—LEP—Alzheimer's disease	2.75e-05	0.000602	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—APOE—Alzheimer's disease	2.75e-05	0.000602	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—LEP—Alzheimer's disease	2.75e-05	0.000602	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CAV1—Alzheimer's disease	2.72e-05	0.000597	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CAV1—Alzheimer's disease	2.72e-05	0.000597	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	2.65e-05	0.00058	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—ESR1—Alzheimer's disease	2.62e-05	0.000575	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—ESR1—Alzheimer's disease	2.62e-05	0.000575	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—F2—Alzheimer's disease	2.59e-05	0.000568	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—F2—Alzheimer's disease	2.59e-05	0.000568	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—NOTCH1—Alzheimer's disease	2.54e-05	0.000556	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—NOTCH1—Alzheimer's disease	2.54e-05	0.000556	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—CA4—Alzheimer's disease	2.41e-05	0.000529	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—GSK3B—Alzheimer's disease	2.38e-05	0.000521	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—GSK3B—Alzheimer's disease	2.38e-05	0.000521	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CREB1—Alzheimer's disease	2.36e-05	0.000517	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CREB1—Alzheimer's disease	2.36e-05	0.000517	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	2.36e-05	0.000517	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—INS—Alzheimer's disease	2.35e-05	0.000514	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—INS—Alzheimer's disease	2.35e-05	0.000514	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CCL2—Alzheimer's disease	2.31e-05	0.000506	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CCL2—Alzheimer's disease	2.31e-05	0.000506	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—IGF1—Alzheimer's disease	2.27e-05	0.000498	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—IGF1—Alzheimer's disease	2.27e-05	0.000498	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—GAPDHS—Alzheimer's disease	2.27e-05	0.000497	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—DHCR24—Alzheimer's disease	2.21e-05	0.000485	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—ATP5A1—Alzheimer's disease	2.15e-05	0.000471	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	2.06e-05	0.000452	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—NOS3—Alzheimer's disease	2.06e-05	0.000451	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—NOS3—Alzheimer's disease	2.06e-05	0.000451	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PLD3—Alzheimer's disease	2.05e-05	0.00045	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	2.05e-05	0.00045	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	2.03e-05	0.000445	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—HSD17B10—Alzheimer's disease	1.97e-05	0.000431	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	1.92e-05	0.000421	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—CYP46A1—Alzheimer's disease	1.89e-05	0.000415	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CA4—Alzheimer's disease	1.88e-05	0.000412	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	1.84e-05	0.000403	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—ND1—Alzheimer's disease	1.83e-05	0.000401	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	1.79e-05	0.000392	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—GAPDHS—Alzheimer's disease	1.77e-05	0.000388	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.76e-05	0.000387	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—AKT1—Alzheimer's disease	1.76e-05	0.000387	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CASP3—Alzheimer's disease	1.75e-05	0.000383	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CASP3—Alzheimer's disease	1.75e-05	0.000383	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—IL6—Alzheimer's disease	1.74e-05	0.000381	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—IL6—Alzheimer's disease	1.74e-05	0.000381	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	1.71e-05	0.000374	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—ATP5A1—Alzheimer's disease	1.68e-05	0.000367	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	1.64e-05	0.000358	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—MAPK8—Alzheimer's disease	1.61e-05	0.000352	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—MAPK8—Alzheimer's disease	1.61e-05	0.000352	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—AKT1—Alzheimer's disease	1.6e-05	0.000351	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—AKT1—Alzheimer's disease	1.6e-05	0.000351	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PLD3—Alzheimer's disease	1.6e-05	0.00035	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	1.6e-05	0.00035	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	1.58e-05	0.000346	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—HSD17B10—Alzheimer's disease	1.53e-05	0.000336	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	1.5e-05	0.000328	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—VEGFA—Alzheimer's disease	1.48e-05	0.000325	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—VEGFA—Alzheimer's disease	1.48e-05	0.000325	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CYP46A1—Alzheimer's disease	1.48e-05	0.000323	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CA4—Alzheimer's disease	1.45e-05	0.000318	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—ND1—Alzheimer's disease	1.43e-05	0.000312	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.41e-05	0.000309	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	1.39e-05	0.000305	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	1.37e-05	0.000299	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—TGFB1—Alzheimer's disease	1.36e-05	0.000298	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—TGFB1—Alzheimer's disease	1.36e-05	0.000298	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	1.29e-05	0.000284	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.28e-05	0.000281	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	1.27e-05	0.000279	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PLD3—Alzheimer's disease	1.23e-05	0.00027	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	1.18e-05	0.000259	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—TPI1—Alzheimer's disease	1.18e-05	0.000258	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—CHAT—Alzheimer's disease	1.18e-05	0.000258	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	1.14e-05	0.00025	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—MAOB—Alzheimer's disease	1.13e-05	0.000248	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—TP53—Alzheimer's disease	1.12e-05	0.000246	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—TP53—Alzheimer's disease	1.12e-05	0.000246	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—ND1—Alzheimer's disease	1.1e-05	0.000241	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.1e-05	0.000241	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—GAPDH—Alzheimer's disease	1.09e-05	0.000238	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.08e-05	0.000236	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.07e-05	0.000234	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—A2M—Alzheimer's disease	1.05e-05	0.00023	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—IL6—Alzheimer's disease	1.03e-05	0.000225	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—IL6—Alzheimer's disease	1.03e-05	0.000225	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1e-05	0.000219	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—AKT1—Alzheimer's disease	9.46e-06	0.000207	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—AKT1—Alzheimer's disease	9.46e-06	0.000207	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	9.37e-06	0.000205	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—TPI1—Alzheimer's disease	9.19e-06	0.000201	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CHAT—Alzheimer's disease	9.19e-06	0.000201	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—ACHE—Alzheimer's disease	9.14e-06	0.0002	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—INPP5D—Alzheimer's disease	9.04e-06	0.000198	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—MAOB—Alzheimer's disease	8.81e-06	0.000193	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PTGS1—Alzheimer's disease	8.57e-06	0.000188	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—ENO1—Alzheimer's disease	8.57e-06	0.000188	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—GAPDH—Alzheimer's disease	8.48e-06	0.000186	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—CYP2D6—Alzheimer's disease	8.4e-06	0.000184	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	8.38e-06	0.000184	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	8.31e-06	0.000182	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—A2M—Alzheimer's disease	8.19e-06	0.000179	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—BCHE—Alzheimer's disease	7.96e-06	0.000174	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PLCB1—Alzheimer's disease	7.51e-06	0.000165	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	7.37e-06	0.000162	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	7.3e-06	0.00016	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—ABCA1—Alzheimer's disease	7.28e-06	0.00016	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—ACHE—Alzheimer's disease	7.12e-06	0.000156	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—TPI1—Alzheimer's disease	7.09e-06	0.000155	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CHAT—Alzheimer's disease	7.09e-06	0.000155	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—INPP5D—Alzheimer's disease	7.04e-06	0.000154	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—MAOB—Alzheimer's disease	6.8e-06	0.000149	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—ENO1—Alzheimer's disease	6.68e-06	0.000146	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PTGS1—Alzheimer's disease	6.68e-06	0.000146	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CYP2D6—Alzheimer's disease	6.55e-06	0.000143	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	6.54e-06	0.000143	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—A2M—Alzheimer's disease	6.32e-06	0.000138	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PPARGC1A—Alzheimer's disease	6.28e-06	0.000138	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—HMOX1—Alzheimer's disease	6.25e-06	0.000137	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—BCHE—Alzheimer's disease	6.21e-06	0.000136	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PLCB1—Alzheimer's disease	5.86e-06	0.000128	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	5.74e-06	0.000126	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—LPL—Alzheimer's disease	5.72e-06	0.000125	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—ABCA1—Alzheimer's disease	5.68e-06	0.000124	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—ACHE—Alzheimer's disease	5.5e-06	0.00012	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	5.43e-06	0.000119	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—ENO1—Alzheimer's disease	5.15e-06	0.000113	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	5.15e-06	0.000113	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—MTHFR—Alzheimer's disease	5.15e-06	0.000113	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	5.05e-06	0.000111	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	4.89e-06	0.000107	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	4.87e-06	0.000107	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—CALM1—Alzheimer's disease	4.81e-06	0.000105	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—APOE—Alzheimer's disease	4.79e-06	0.000105	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—BCHE—Alzheimer's disease	4.79e-06	0.000105	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—CAV1—Alzheimer's disease	4.75e-06	0.000104	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	4.52e-06	9.9e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—LPL—Alzheimer's disease	4.45e-06	9.76e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	4.38e-06	9.6e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PPARG—Alzheimer's disease	4.17e-06	9.14e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—INS—Alzheimer's disease	4.09e-06	8.97e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	4.01e-06	8.79e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	3.78e-06	8.27e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	3.76e-06	8.23e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CALM1—Alzheimer's disease	3.75e-06	8.21e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—APOE—Alzheimer's disease	3.73e-06	8.18e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CAV1—Alzheimer's disease	3.7e-06	8.1e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—NOS3—Alzheimer's disease	3.59e-06	7.86e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—LPL—Alzheimer's disease	3.44e-06	7.53e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PTGS2—Alzheimer's disease	3.28e-06	7.19e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PPARG—Alzheimer's disease	3.25e-06	7.12e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—INS—Alzheimer's disease	3.19e-06	6.99e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	3.09e-06	6.78e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CALM1—Alzheimer's disease	2.89e-06	6.33e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—APOE—Alzheimer's disease	2.88e-06	6.31e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CAV1—Alzheimer's disease	2.85e-06	6.25e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—NOS3—Alzheimer's disease	2.8e-06	6.13e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	2.56e-06	5.6e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PPARG—Alzheimer's disease	2.51e-06	5.5e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—INS—Alzheimer's disease	2.46e-06	5.39e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—NOS3—Alzheimer's disease	2.16e-06	4.73e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	1.97e-06	4.33e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—AKT1—Alzheimer's disease	1.65e-06	3.62e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—AKT1—Alzheimer's disease	1.29e-06	2.82e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—AKT1—Alzheimer's disease	9.92e-07	2.17e-05	CbGpPWpGaD
